| Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico LM Dunkle, KL Kotloff, CL Gay, G Áñez, JM Adelglass, ... New England Journal of Medicine 386 (6), 531-543, 2022 | 357 | 2022 |
| Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial P Bégin, J Callum, E Jamula, R Cook, NM Heddle, A Tinmouth, MP Zeller, ... Nature medicine 27 (11), 2012-2024, 2021 | 240 | 2021 |
| Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression AF Rendeiro, J Casano, CK Vorkas, H Singh, A Morales, RA DeSimone, ... Life science alliance 4 (2), 2021 | 58 | 2021 |
| The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services Y Aponte-Melendez, P Mateu-Gelabert, C Fong, B Eckhardt, S Kapadia, ... Harm reduction journal 18 (1), 1-12, 2021 | 43 | 2021 |
| Hepatitis C management simplification from test to cure: a framework for primary care providers SN Kapadia, KM Marks Clinical therapeutics 40 (8), 1234-1245, 2018 | 41 | 2018 |
| The expanding role of antimicrobial stewardship programs in hospitals in the United States: lessons learned from a multisite qualitative study SN Kapadia, EL Abramson, EJ Carter, AS Loo, R Kaushal, DP Calfee, ... The Joint Commission Journal on Quality and Patient Safety 44 (2), 68-74, 2018 | 41 | 2018 |
| Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City CN Behrends, D Paone, ML Nolan, E Tuazon, SM Murphy, SN Kapadia, ... Journal of substance abuse treatment 106, 79-88, 2019 | 37 | 2019 |
| Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial B Eckhardt, P Mateu-Gelabert, Y Aponte-Melendez, C Fong, S Kapadia, ... JAMA Internal Medicine 182 (5), 494-502, 2022 | 35 | 2022 |
| Microbial composition of the human nasopharynx varies according to influenza virus type and vaccination status T Ding, T Song, B Zhou, A Geber, Y Ma, L Zhang, M Volk, SN Kapadia, ... MBio 10 (4), 10.1128/mbio. 01296-19, 2019 | 29 | 2019 |
| A harm reduction approach to treating opioid use disorder in an independent primary care practice: a qualitative study SN Kapadia, JL Griffin, J Waldman, NR Ziebarth, BR Schackman, ... Journal of General Internal Medicine, 1-8, 2021 | 28 | 2021 |
| State Medicaid hepatitis C treatment eligibility criteria and use of direct-acting antivirals SN Kapadia, PJ Jeng, BR Schackman, Y Bao Clinical Infectious Diseases 66 (10), 1618-1620, 2018 | 28 | 2018 |
| Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020 CN Behrends, X Lu, GJ Corry, P LaKosky, SM Prohaska, SN Glick, ... Drug and alcohol dependence 232, 109323, 2022 | 26 | 2022 |
| Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination C Katzman, P Mateu-Gelabert, SN Kapadia, BJ Eckhardt International Journal of Drug Policy 72, 33-39, 2019 | 25 | 2019 |
| Strategies for improving hepatitis C treatment access in the US: State officials address high drug prices, stigma, and building treatment capacity SN Kapadia, CD Johnston, KM Marks, BR Schackman, EG Martin Journal of public health management and practice: JPHMP 25 (3), 245, 2019 | 24* | 2019 |
| Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City C Fong, P Mateu-Gelabert, C Ciervo, B Eckhardt, Y Aponte-Melendez, ... Drug and Alcohol Dependence 221, 108589, 2021 | 23 | 2021 |
| Impact of diagnostic bone biopsies on the management of non-vertebral osteomyelitis: A retrospective cohort study CB Hirschfeld, SN Kapadia, J Bryan, DP Jannat-Khah, B May, ... Medicine 98 (34), 2019 | 21 | 2019 |
| Metabolic and immune markers for precise monitoring of COVID-19 severity and treatment AF Rendeiro, CK Vorkas, J Krumsiek, HK Singh, SN Kapadia, LV Cappelli, ... Frontiers in Immunology 12, 809937, 2022 | 17 | 2022 |
| Elevated inflammatory markers are associated with poor outcomes in COVID‐19 patients treated with remdesivir K Stoeckle, B Witting, S Kapadia, A An, K Marks Journal of Medical Virology 94 (1), 384-387, 2022 | 17 | 2022 |
| Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression AF Rendeiro, J Casano, CK Vorkas, H Singh, A Morales, RA DeSimone, ... medRxiv, 2020 | 16 | 2020 |
| Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder N Tabatabaeepour, JR Morgan, A Jalali, SN Kapadia, A Meinhofer Journal of substance abuse treatment 140, 108800, 2022 | 15 | 2022 |
Czarina N. BehrendsAssistant Professor of Population Health Sciences at Weill Cornell MedicineVerificeret mail på med.cornell.edu
